Abstract
Sarcomas are a common type of tumor within the pediatric population. The utilization of proton therapy as a primary attribute the ability to spare adjacent healthy tissue, therefore, proton therapy has become a preferential indication in pediatrics compared to other photon irradiation modalities. Proton therapy is also a proven and historically validated irradiation technique in the treatment of chondrosarcomas and chordomas of the skull base and spine. Additionally, proton therapy can potentially limit irradiated healthy tissue volumes in adults and limit the risk of acute and late toxicities. The evaluation of the effectiveness of proton therapy in sarcomas is underway in many clinical situations in prospective trials, some of which are randomized.
Original language | English |
---|---|
Pages (from-to) | 830-838 |
Number of pages | 9 |
Journal | Bulletin du Cancer |
Volume | 105 |
Issue number | 9 |
DOIs | |
Publication status | Published - Sept 2018 |
Externally published | Yes |
Keywords
- Hadrontherapy
- Level of evidence
- Proton therapy
- Sarcoma